Jerry Bagel, MD, director of the Psoriasis Treatment Center of New Jersey, sheds light on the clinical utility of newer classes of biologic agents in the management of psoriasis and psoriatic arthritis.
An Interview With Jerry Bagel, MD
Advertisement
Articles by An Interview With Jerry Bagel, MD
Advertisement
Latest Updated Articles
Practical Insights on the Changing Spectrum of Biologic Agents for the Treatment of Patients With Psoriatic DiseasePublished: May 23rd 2020 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Newly Unveiled ACA Premiums Show 26% Average Increase Before Subsidy Expiration
2
FDA Guidance to Remove One of the Largest Barriers to Biosimilar Development
3
Measles Outbreaks Cause Financial, Public Health Burden in US
4
New PBM Laws Seek to Protect Independent Pharmacies but Could Raise Costs, Limit Patient Access
5
